HBIO President Announces Completion of Stock Transactions under 10b5-1 Plan.HOLLISTON, Mass. -- Harvard Bioscience, Inc., (Nasdaq: HBIO) today announced that its president, David Green, has completed the stock transactions under a stock-trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 which was adopted on March 14, 2006. The plan was adopted during an authorized trading period at a time when Mr. Green was not in possession of material, non-public information. About Harvard Bioscience Harvard Bioscience (HBIO) is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily scientific instruments and apparatus, used to advance life science research at pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , universities and government laboratories worldwide. HBIO sells its products to thousands of researchers in over 100 countries through its 1,100 page catalog (and various other specialty catalogs Specialty catalogs are a promotion and distribution technique commonly employed by direct marketers. They describe, graphically and verbally, a limited range of products. Specialty catalogs are a good promotion/distribution choice for new products. ), its website and through its distributors, including GE Healthcare GE Healthcare is a $18 billion (USD) unit of General Electric (GE). It employs more than 46,000 people worldwide and is headquartered in Chalfont St. Giles, Buckinghamshire, United Kingdom. GE Healthcare is the first GE business segment headquartered outside the United States. , Fisher Scientific Fisher Scientific, formally Fisher Scientific International, Inc. and colloquially Fisher was a biotechnology company that provided products and services to the global scientific research and United States clinical laboratory markets. and VWR VWR Van Waters and Rogers VWR Viewer File . HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany, and Austria with additional facilities in France and Canada. For more information, please visit www.harvardbioscience.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion